Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review

Abstract Objective Bupropion, an antidepressant inhibiting the reuptake of dopamine and noradrenaline, should be useful to treat depressive symptoms in patients with Parkinson’s disease (PD). Limited and conflicting literature data questioned its effectiveness and safety in depressed PD patients and...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Matteo Vismara, Beatrice Benatti, Gregorio Nicolini, Ilaria Cova, Edoardo Monfrini, Alessio Di Fonzo, Vincenza Fetoni, Caterina A. Viganò, Alberto Priori, Bernardo Dell’Osso
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-05-01
coleção:	BMC Neurology
Assuntos:	Bupropion Parkinson’s disease Depression Neuropsychiatric symptoms Pharmacological treatment
Acesso em linha:	https://doi.org/10.1186/s12883-022-02668-4
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!